drugset / Trial / NCT05875441
Efficacy and Safety Study of Moxidectin in Adults With Scabies
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Moxidectin is not approved to treat scabies in humans. The effective dose of moxidectin to treat scabies is not known. This study aims to assess the efficacy of a single administration of 8 mg, 16 mg, or 32 mg moxidectin per oral in achieving Scabies Complete Cure at Day 28. This study also aims to assess the safety of three strengths of single moxidectin doses in adults with scabies.
Timeline
- Start
- 2023-11-23
- Primary completion
- 2024-11-27
- Completion
- 2025-02-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Moxidectin | Other / unclassified | 8 mg | — |
| Subject | Moxidectin | Other / unclassified | 16 mg | — |
| Subject | Moxidectin | Other / unclassified | 32 mg | — |